What is percutaneous coronary intervention (PCI)?

What is Percutaneous Coronary Intervention (PCI)?

Percutaneous coronary intervention (PCI) is a catheter-based procedure that encompasses balloon angioplasty, intracoronary stenting, and other percutaneous techniques (atherectomy, thrombectomy, laser angioplasty) used to relieve coronary artery narrowing and restore blood flow to ischemic myocardium. 1

Core Definition and Terminology

• PCI is the modern umbrella term that replaced the older designation "PTCA" (percutaneous transluminal coronary angioplasty), which referred specifically to balloon angioplasty alone 1, 2
• The ACC/AHA guidelines formally adopted "PCI" to reflect the evolution beyond simple balloon dilation to include stenting and atheroablative technologies 1
• The procedure is performed by introducing a catheter system through a systemic artery under local anesthesia into the stenotic coronary artery, where controlled inflation of a distensible balloon or deployment of a stent relieves the obstruction 3

Components of Modern PCI

The procedure includes multiple technical approaches:

• Standard balloon angioplasty (PTCA) - the foundational technique using balloon inflation to dilate narrowed arteries 1, 2
• Intracoronary stent implantation - now used in 80-85% of PCI procedures in the United States, dramatically reducing acute vessel closure and restenosis rates compared to balloon-only techniques 1
• Drug-eluting stents (DES) - which markedly reduce restenosis risk compared to bare-metal stents 1
• Atheroablative technologies including rotational atherectomy, directional atherectomy, extraction atherectomy, and laser angioplasty 1, 2
• Thrombectomy devices - used in specific lesion subsets, though clinical outcome benefits remain less established 1

Procedural Timing Definition

• PCI procedure start time is defined as when local anesthetic is first administered for vascular access, or the time of first vascular access attempt, whichever occurs earlier 1
• Any attempt to treat a stenosis by any technique—even failed attempts to cross the stenosis with a wire or device—counts as PCI 1

Primary Clinical Applications

PCI serves two fundamental purposes:

Symptom Relief

• The primary benefit in stable coronary artery disease is relief of angina symptoms, not survival improvement in most patients 4
• PCI provides more angina relief than placebo procedures in patients with stable angina and evidence of ischemia on minimal antianginal therapy 1

Prognostic Benefit in Specific Populations

• Primary PCI is the recommended revascularization strategy for ST-elevation myocardial infarction (STEMI), with goal door-to-balloon time within 90 minutes 1, 5
• Early invasive strategy with PCI improves outcomes in high-risk unstable angina/non-ST-elevation MI patients with recurrent ischemia, dynamic ST changes, elevated troponins, or hemodynamic instability 1, 4
• Revascularization may improve survival in left main disease >50%, three-vessel disease (especially with reduced ejection fraction), and proximal LAD disease with extensive ischemia 4

Adjunctive Pharmacological Advances

Modern PCI success depends heavily on pharmacological support:

• Glycoprotein IIb/IIIa receptor antagonists reduce procedure-related myocardial infarctions from approximately 10% to 5% 1
• Dual antiplatelet therapy with thienopyridines (clopidogrel, prasugrel, ticagrelor) is essential for preventing stent thrombosis 1
• Bivalirudin provides alternative anticoagulation during PCI 1, 2

Operator and Facility Requirements

• Operators must perform a minimum of 50 PCIs per year at hospitals performing at least 200 PCIs annually to maintain competency, according to 2013 ACC/AHA/SCAI standards (relaxed from prior 75 PCIs/operator at centers with >400 PCIs/year) 6
• The guidelines assume operators possess both cognitive and technical skills for PCI and that appropriate facilities and resources are available 1, 2

Intravascular Imaging Guidance

• Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) provide superior vessel and plaque characterization compared to angiography alone, optimizing lesion preparation, stent sizing, and deployment 1
• Despite proven benefits, intravascular imaging is currently used in <15% of PCI procedures, representing a significant practice gap 1

Common Procedural Complications

• Approximately 30% of patients undergoing elective PCI sustain some degree of peri-procedural myocardial injury, detectable by sensitive biomarkers (CK-MB, troponin) or cardiac MRI 7
• Historical complications of balloon angioplasty included acute vessel closure (5%) and restenosis (35-45% at 6 months), both dramatically reduced by stenting 1

Critical Clinical Caveats

• PCI should not be performed without objective evidence of ischemia on noninvasive testing in stable patients—this is a Class III (harm) recommendation 8, 4
• For diabetic patients with multivessel disease, CABG provides superior survival compared to PCI (5-year survival 80.6% vs 65.5%, p=0.0003 in BARI trial) 4
• Significant left main disease (>50% stenosis) in CABG-eligible patients is a contraindication to PCI 1, 8